Trademark Search in Canada

BEYOND INSULIN

View On IC.GC.CA

ADVERTISED

on 11 Dec 2024

Last Applicant/ Owned by

Breakthrough T1D

200 Vesey Street, 28th FloorNew York, NY 10281

Serial Number

2104403 filed on 4^th May 2021

Correspondent Address

ROBERT H. NAKANO

(GARDINER ROBERTS LLP)Bay Adelaide Center - East Tower22 Adelaide St West, Suite 3600Toronto

ONTARIO

M5H4E3

BEYOND INSULIN

Trademark usage description

charitable fundraising services relating to type 1 diabetes (t1d); management of finances, namely accepting and administering monetary charitable cont Read More

Classification Information

Class [036]
Charitable fundraising services relating to type 1 diabetes (T1D); Management of finances, namely accepting and administering monetary charitable contributions to fund research into cures, treatments, and preventions for type 1 diabetes (T1D)

Classification kind code

Mark Details

Serial Number

2104403

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 11^th Dec 2024	Advertised
Submitted for opposition 26 on 13^th Nov 2024	Approved
Submitted for opposition 27 on 13^th Nov 2024	Approval Notice Sent
Submitted for opposition 22 on 4^th Nov 2024	Search Recorded
Submitted for opposition 135 on 1^st Nov 2024	Amendment to Application
Submitted for opposition 287 on 4^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 4^th May 2021	Filed
Submitted for opposition 1 on 4^th May 2021	Created
Submitted for opposition 31 on 4^th May 2021	Formalized

BEYOND INSULIN

Classification Information

Class [036]Charitable fundraising services relating to type 1 diabetes (T1D); Management of finances, namely accepting and administering monetary charitable contributions to fund research into cures, treatments, and preventions for type 1 diabetes (T1D)

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [036]
Charitable fundraising services relating to type 1 diabetes (T1D); Management of finances, namely accepting and administering monetary charitable contributions to fund research into cures, treatments, and preventions for type 1 diabetes (T1D)